Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
about
Concerning RNA-guided gene drives for the alteration of wild populations"Off-Spotter": very fast and exhaustive enumeration of genomic lookalikes for designing CRISPR/Cas guide RNAsCRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systemsA CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiaeCpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas systemCRISPR-Cas9 Genome Editing in DrosophilaRecent Advances in Genome Editing Using CRISPR/Cas9CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative DiseasesCustomizing the genome as therapy for the β-hemoglobinopathiesThe CRISPR/Cas Genome-Editing Tool: Application in Improvement of CropsGenome Engineering with TALE and CRISPR Systems in NeuroscienceBrain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureThe Rise of CRISPR/Cas for Genome Editing in Stem CellsThe therapeutic potential of genome editing for β-thalassemiaCRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic VirusesGenome-editing Technologies for Gene and Cell TherapyAdvanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the BrainGenome Editing and Its Applications in Model OrganismsTowards a new era in medicine: therapeutic genome editingTargeting Non-Coding RNAs in Plants with the CRISPR-Cas Technology is a Challenge yet Worth AcceptingApplications of CRISPR-Cas systems in neuroscienceHow specific is CRISPR/Cas9 really?Origins of Programmable Nucleases for Genome EngineeringMinimizing off-Target Mutagenesis Risks Caused by Programmable NucleasesApplication of CRISPR/Cas9 Technology to HBVFrom Gene Targeting to Genome Editing: Transgenic animals applications and beyondEnabling functional genomics with genome engineeringDissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing toolsDesigned nucleases for targeted genome editingUse of designer nucleases for targeted gene and genome editing in plantsMitochondrial targets for pharmacological intervention in human diseaseAdvances in CRISPR-Cas9 genome engineering: lessons learned from RNA interferenceOff-target Effects in CRISPR/Cas9-mediated Genome EngineeringEpigenome engineering in cancer: fairytale or a realistic path to the clinic?Making designer mutants in model organismsMeasuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9Genetic and genomic tools for the marine annelid Platynereis dumeriliiRNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processesMultiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow.Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes
P2860
Q21128771-16F059F3-9D64-49F3-BDB1-252BE77F0B4EQ21146629-04964957-65D8-49D3-930D-2E3C2F21081FQ21558788-86D97977-97B0-45DC-A4C8-32460FA3A17EQ24456430-3A735301-C0DC-4B2E-A3E7-A21416799395Q24669821-D00D841E-8801-4063-8ABF-3AF5A66B7F23Q26314632-85530C12-F2BA-4AEA-ADEB-691124AAEBF5Q26744073-A58D3DC8-82A5-4AA7-9012-5A9D76B44585Q26747564-62F77B86-0EF4-44EF-8E90-BE095648C540Q26751061-32535BF2-6D5A-4FCB-B507-3309FF0C28D5Q26752469-F3A4E022-AF68-4E5F-81BD-9F15620E116FQ26752488-0F23E697-3CB8-4D62-A61A-279E4B2EAFC1Q26753206-B46859F8-E9ED-45B4-B08E-F5EF788427D1Q26765852-3F23CF0F-409A-464E-8A85-029F0AAA5DAAQ26766232-983BDE34-7349-4A76-80B8-FB5289FC4E13Q26766798-217C7853-BFCD-4D23-BC54-8A811BACFB9FQ26769662-DA1EC7E3-9497-49CE-96AB-137017E5EFBBQ26770355-2FF6C5D2-A38C-4F59-AD5A-B6E5CDFE1651Q26772108-267E5196-8C32-4A9C-A252-3661CEC36C0CQ26773287-70123B88-DA64-4DAE-A7C9-CF9E6C041C93Q26774632-991210BC-0A71-472E-A5B5-3ECEF9672325Q26776515-D16645BC-2FE0-4D85-988E-6CFC149074C0Q26777801-3B01082B-1687-4930-9017-C2100139A38CQ26778501-51CD0EF1-E624-4FDA-A9E5-A4ADBF9EB1F7Q26778992-6A125A26-D80E-4773-977C-A7D0F6690FF6Q26779150-2C007D7A-8E1F-4876-AA25-E4481BD13283Q26781859-0CF62EC5-6BAD-4206-A4CF-BC72584CB5AFQ26782747-DF9ADC7B-033F-4272-9CE0-07B6103F034BQ26785684-17AB098F-46A5-4E69-987D-5248DBA31C71Q26787105-6A818F16-6030-4A89-B9CB-9277A63DB356Q26799592-8DA839CC-CC84-43DE-B819-80A278CC7E63Q26824514-DCE9F285-59C1-419B-B43A-ED703D21B3F2Q26852489-81245946-C063-4401-AF6F-D1BC1588EFD0Q26859390-A7431040-7C8E-46D1-AD35-5996B592C57AQ26861350-046562CA-35E9-4D10-981D-DF5E3993F3E4Q27010108-43FD80E4-E2B4-4785-B2EC-14A9EEFDD5C8Q27011906-3A8ACE82-48B4-4009-8E5D-2C2B144853E0Q27024130-6B3E66C0-78D1-464E-BA17-F0D533DB0BFAQ27025675-9C4507E3-DE48-46C7-A0F4-4B57D16C989DQ27313598-59626FDB-5E02-4BF2-B1B1-3ABA242076CFQ27321083-1352A9BC-9EAE-4804-8E9A-9D3821A0E802
P2860
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
@ast
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
@en
type
label
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
@ast
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
@en
prefLabel
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
@ast
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
@en
P2093
P2860
P3181
P356
P1433
P1476
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/NBT.2808
P407
P577
2014-03-01T00:00:00Z
P5875
P6179
1048637524